Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy

Antonio Bulbena, Eila Monteagudo-Gimeno, R. Sánchez-González, Joaquim Raduà, Lydia Fortea, Teresa Boget-Llucià, Maria del Mar Carreño Martínez, Antonio Jesús Donaire-Pedraza, Nuria Bargalló, Xavier Setoain, Jordi Rumià-Arboix, Luis Pintor-Pérez

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Depressive/anxious disorders and cognitive impairment are frequent comorbidities in epilepsy and have a more deleterious effect in DRE.•Studies concerning the relationship between anxiety and depression and cognitive performance in DRE are scarce.•Higher scores in HADS are associated with lower QOLIE-31 scores and might be considered as predictors of QOL in DRE.•A relationship between anxious and depressive symptoms -measured with HADS and SCL-90R- and cognition might not exist.•There remains an unexplored study area regarding this relationship which requires more attention to improve the assessment of DRE.
Original languageEnglish
Article numbere20903
Number of pages8
JournalHeliyon
Volume9
Issue number10
DOIs
Publication statusPublished - Oct 2023

Fingerprint

Dive into the research topics of 'Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy'. Together they form a unique fingerprint.

Cite this